GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: Further study revealed GATA2 ZF1 mutants, but not the ZF2 L359V that is commonly seen at the progression of CML to blast crisis, had reduced capacity to enhance CEBPA-dependent activation of transcription9.